Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1154

1.

Radiochemotherapy with cisplatin and oral tegafur in advanced head and neck cancer: long-term results of a phase II study.

de la Torre A, Romero J, Montero A, Garcia-Berrocal MI, Valcarcel FJ, Cordoba S, Magallon R.

Tumori. 2008 Jul-Aug;94(4):453-8.

PMID:
18822677
2.

Intensive concomitant chemoradiotherapy in locally advanced unresectable squamous cell carcinoma of the head and neck: a phase II study of radiotherapy with cisplatin and 7-week continuous infusional fluorouracil.

Wibault P, Bensmaine MA, de Forni M, Armand JP, Tellez Bernal E, Guillot T, Recondo G, Domenge C, Janot F, Borel C, Luboinski B, Eschwege F, Cvitkovic E.

J Clin Oncol. 1996 Apr;14(4):1192-200.

PMID:
8648374
3.

Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck.

Merlano M, Benasso M, Corvò R, Rosso R, Vitale V, Blengio F, Numico G, Margarino G, Bonelli L, Santi L.

J Natl Cancer Inst. 1996 May 1;88(9):583-9.

4.

Concomitant chemoradiotherapy using carboplatin, tegafur-uracil and leucovorin for stage III and IV head-and-neck cancer: results of GORTEC Phase II study.

Fesneau M, Pointreau Y, Chapet S, Martin L, Pommier P, Alfonsi M, Laguerre B, Feham N, Berger C, Garaud P, Calais G.

Int J Radiat Oncol Biol Phys. 2010 Jan 1;76(1):154-63. doi: 10.1016/j.ijrobp.2009.01.033. Epub .

PMID:
19386430
5.
6.

Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II study.

Chang PM, Chen PM, Chu PY, Wang LW, Tai SK, Tsai TL, Huang JL, Wang YF, Chang SY, Yang MH.

Cancer Chemother Pharmacol. 2008 Dec;63(1):9-17. doi: 10.1007/s00280-008-0702-1. Epub 2008 Mar 15.

PMID:
18343925
7.

Cisplatin, fluorouracil, and leucovorin induction chemotherapy followed by concurrent cisplatin chemoradiotherapy for organ preservation and cure in patients with advanced head and neck cancer: long-term follow-up.

Psyrri A, Kwong M, DiStasio S, Lekakis L, Kassar M, Sasaki C, Wilson LD, Haffty BG, Son YH, Ross DA, Weinberger PM, Chung GG, Zelterman D, Burtness BA, Cooper DL.

J Clin Oncol. 2004 Aug 1;22(15):3061-9.

8.

Preoperative cisplatin and accelerated hyperfractionated radiation induces high tumor response and control rates in patients with advanced head and neck cancer.

Wanebo HJ, Glicksman AS, Landman C, Slotman G, Doolittle C, Clark J, Koness RJ.

Am J Surg. 1995 Nov;170(5):512-6.

PMID:
7485745
9.

Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.

Athanasiadis I, Taylor S 4th, Vokes EE, Pelzer HJ, Rademaker A, Mittal BB, Ganzenko N, Blough R, Lester EP, Kies MS.

Cancer. 1997 Feb 1;79(3):588-94.

PMID:
9028372
10.

Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck.

Tribius S, Kronemann S, Kilic Y, Schroeder U, Hakim S, Schild SE, Rades D.

Strahlenther Onkol. 2009 Oct;185(10):675-81. doi: 10.1007/s00066-009-1992-x. Epub 2009 Oct 6.

PMID:
19806333
12.

A randomized phase II study comparing sequential versus simultaneous chemo-radiotherapy in patients with unresectable locally advanced squamous cell cancer of the head and neck.

Pinnarò P, Cercato MC, Giannarelli D, Carlini P, Del Vecchio MR, Impiombato FA, Marzetti F, Milella M, Cognetti F.

Ann Oncol. 1994 Jul;5(6):513-9.

PMID:
7918123
13.

Accelerated bifractionated radiation with concurrent cisplatin administration in locally advanced head and neck cancer: a feasibility study.

Fountzilas G, Athanassiadis A, Nikolaou A, Kalogera-Fountzila A, Tzitzikas J, Samantas E, Skarlos D, Zamboglou N, Daniilidis J.

Tumori. 1997 Jul-Aug;83(4):735-9.

PMID:
9349312
14.

Cisplatin, fluorouracil, and L-leucovorin induction chemotherapy for locally advanced head and neck cancer: the M.D. Anderson Cancer Center experience.

Papadimitrakopoulou VA, Dimery IW, Lee JJ, Perez C, Hong WK, Lippman SM.

Cancer J Sci Am. 1997 Mar-Apr;3(2):92-9.

PMID:
9099459
16.
17.

Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.

Haraf DJ, Kies M, Rademaker AW, Stenson K, Mittal B, Pelzer H, Wenig B, Witt ME, Sulzen L, Weichselbaum RR, Vokes EE.

J Clin Oncol. 1999 Feb;17(2):638-44.

PMID:
10080609
19.

Randomized comparison of neoadjuvant cisplatin and fluorouracil infusion followed by radiation versus concomitant treatment in advanced head and neck cancer.

Taylor SG 4th, Murthy AK, Vannetzel JM, Colin P, Dray M, Caldarelli DD, Shott S, Vokes E, Showel JL, Hutchinson JC, et al.

J Clin Oncol. 1994 Feb;12(2):385-95.

PMID:
8113846
20.

A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas.

Medina JA, Rueda A, de Pasos AS, Contreras J, Cobo M, Moreno P, Benavides M, Villanueva A, Alba E.

Radiother Oncol. 2006 Apr;79(1):34-8. Epub 2006 Apr 19.

PMID:
16626826
Items per page

Supplemental Content

Write to the Help Desk